EP Patent

EP0788480A1 — Crystallisation of levobupivacaine and analogues thereof

Assigned to Darwin Discovery Ltd · Expires 1997-08-13 · 29y expired

What this patent protects

Levobupivacaine or an analogue thereof is prepared by reaction with a tartaric acid resolving agent in a solvent, in the presence of water and/or less than 0.5 equivalents of the resolving agent.

USPTO Abstract

Levobupivacaine or an analogue thereof is prepared by reaction with a tartaric acid resolving agent in a solvent, in the presence of water and/or less than 0.5 equivalents of the resolving agent.

Drugs covered by this patent

Bupivacaine Hydrochloride And Epinephrine (BUPIVACAINE) · Innocoll

Patent Metadata

Patent number: EP0788480A1
Jurisdiction: EP
Classification: —
Expires: 1997-08-13
Drug substance claim: No
Drug product claim: No
Assignee: Darwin Discovery Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.